- Home
- MIRM vs GBCI Comparison
MIRM vs GBCI Comparison
Compare MIRM & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRM | GBCI |
|---|---|---|
| Founded | 2018 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 6.0B |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MIRM | GBCI |
|---|---|---|
| Price | $122.61 | $51.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $119.85 | $54.00 |
| AVG Volume (30 Days) | 855.5K | ★ 1.1M |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.74% |
| EPS Growth | ★ 74.59 | 18.45 |
| EPS | N/A | ★ 0.63 |
| Revenue | ★ $19,138,000.00 | N/A |
| Revenue This Year | $26.22 | $31.52 |
| Revenue Next Year | $22.04 | $8.46 |
| P/E Ratio | ★ N/A | $82.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $47.89 | $39.90 |
| 52 Week High | $124.44 | $53.99 |
Technical Indicators
Market Signals| Indicator | MIRM | GBCI |
|---|---|---|
| Relative Strength Index (RSI) | 77.72 | 65.68 |
| Support Level | $87.93 | $47.29 |
| Resistance Level | N/A | $53.99 |
| Average True Range (ATR) | 5.12 | 1.24 |
| MACD | 2.70 | 0.35 |
| Stochastic Oscillator | 92.41 | 87.12 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About GBCI Glacier Bancorp Inc.
Glacier Bancorp Inc is a regional bank holding company providing commercial banking services through its wholly owned bank subsidiary, Glacier Bank. The group provides a full range of banking services to individuals, small to medium-sized businesses, community organizations, and public entities from several locations in Montana, Idaho, Utah, Washington, Wyoming, Colorado, Arizona, Nevada, and Texas. It offers various banking products and services, including: retail banking, business banking, real estate, commercial, agriculture, and consumer loans; and mortgage origination and loan servicing services, among others.